Furthermore, a study by Nho et al. (2019)  demonstrated demonstrated that lower serum ALT levels and an elevated AST/ALT ratio in individuals with Alzheimer’s disease (AD) are associated with poorer cognitive abilities, reduced brain glucose metabolism, and the deposition of amyloid-beta (Aβ). The gene discussed is GPT; the disease is Alzheimer disease.